Author/Authors :
Rehman, Suhailur Department of Pathology - Jawaharlal Nehru Medical College - Aligarh Muslim University, Aligarh, Uttar Pradesh, India , Arif, S. H Department of Pathology - Jawaharlal Nehru Medical College - Aligarh Muslim University, Aligarh, Uttar Pradesh, India , Kumar, Amit Hind Institute of Medical Sciences, Lucknow, Uttar Pradesh, India , Khan, A. Q Department of Orthopaedic Surgery - Jawaharlal Nehru Medical College - Aligarh Muslim University, Aligarh, Uttar Pradesh, India
Abstract :
Nowadays, the prevalence of Multiple Myeloma (MM) seems to have been increasing among young females. Here, we report that thalidomide is contraindicated in pregnant women diagnosed with MM and those desirous of subsequent pregnancy. In this case report, we compared the clinical response of Thalidomide-Dexamethasone therapy in a post-abortive woman with persistently elevated β-hCG levels due to retained products of conception, undergoing hysterectomy later. This case report underlines the clinical significance of age, the effect of Thalidomide-Dexamethasone therapy even after initial discontinuation and the response to high β-hCG levels.
Keywords :
High β-hCG levels , Thalidomide-dexamethasone therapy , Post-aborted woman , Multiple myeloma
